These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 7171306)

  • 1. Measles vaccination. Serologic response and persistence of antibody titer by age at vaccination.
    Biberi-Moroeanu S; Munţiu A; Tiţeica M
    Arch Roum Pathol Exp Microbiol; 1982; 41(4):347-55. PubMed ID: 7171306
    [No Abstract]   [Full Text] [Related]  

  • 2. [Status of immunization against measles in the pediatric population of the province of Ferrara].
    Bezzi TM; Soriani S; Trombini R; Scorrano M
    Minerva Pediatr; 1980 Apr; 32(8):581. PubMed ID: 7393191
    [No Abstract]   [Full Text] [Related]  

  • 3. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
    Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
    J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on the persistence of immunity 14-15 years after vaccination with a live measles vaccine].
    Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):389-91. PubMed ID: 2598095
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunologic response and reactions to vaccination in children vaccinated against measles. III. Persistence of measles antibodies in children vaccinated in 1972].
    Kańtoch M; Naruszewicz-Lesiuk D; Polna I; Lityńska J
    Przegl Epidemiol; 1976; 30(2):235-41. PubMed ID: 945592
    [No Abstract]   [Full Text] [Related]  

  • 6. Measles susceptibility in two Pacific atoll populations. Epidemiological factors and response to live attenuated measles virus.
    Willis MF; Warburton MF
    Med J Aust; 1974 May; 1(20):789-93. PubMed ID: 4853112
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on further attenuated liver measles vaccine. VII. Development and evaluation of CAM-70 measles virus vaccine.
    Okuno Y; Ueda S; Kurimura T; Suzuki N; Yamanishi K
    Biken J; 1971 Sep; 14(3):253-8. PubMed ID: 5167868
    [No Abstract]   [Full Text] [Related]  

  • 8. [Reaction to vaccination and measles antibody levels in children inoculated with vaccine prepared from the L-16 strain from Japanese quail embryonic fibroblast cultures].
    Zespolowa P
    Przegl Epidemiol; 1975; 29(3):291-300. PubMed ID: 1178922
    [No Abstract]   [Full Text] [Related]  

  • 9. Optimum age for measles immunisation: study of pre- and post-immunization level of HI antibody titres.
    Bhatnagar SK; Mohan M; Kumar P; Balaya S; Prabhakar AK; Bhargava SK
    Indian Pediatr; 1981 Sep; 18(9):625-9. PubMed ID: 6797943
    [No Abstract]   [Full Text] [Related]  

  • 10. [Measles vaccination: study of humoral immunity in children vaccinated in the Tunis region].
    Arrouji A; Mirchamsy H; Marnissi A
    Arch Inst Pasteur Tunis; 1982 Mar; 59(1):173-80. PubMed ID: 7181563
    [No Abstract]   [Full Text] [Related]  

  • 11. Measles vaccine: immunity, reinfection and revaccination.
    Linnemann CC
    Am J Epidemiol; 1973 Jun; 97(6):365-71. PubMed ID: 4713932
    [No Abstract]   [Full Text] [Related]  

  • 12. Serological survey of measles in Yemen in 1985.
    Strauss J; Dobahi SS; Danes L; Kopecký K; Svandová E
    J Hyg Epidemiol Microbiol Immunol; 1989; 33(1):71-4. PubMed ID: 2723425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dynamics of the serologic response of children vaccinated with live AMN USSR measles vaccine prepared from the ESzCz strain].
    Sinjak KM; Czumakow MP; Rodin WI; Czudnaja LM; Sziechtier AB; Winograd IA; Urin AI; Glinskaja LA; Szwiec LT; Knjaziewa II; Niemiec ZA
    Przegl Epidemiol; 1970; 24(1):15-20. PubMed ID: 5431385
    [No Abstract]   [Full Text] [Related]  

  • 14. [Unsuitability of children revaccination against measles].
    Bolotovskiĭ VM; Titova NS
    Sov Med; 1981; (9):43-8. PubMed ID: 7313794
    [No Abstract]   [Full Text] [Related]  

  • 15. [Serologic diagnosis of measles].
    Vanista J; Havlík J; Kulková H
    Kinderarztl Prax; 1974 Jan; 42(1):30-6. PubMed ID: 4136273
    [No Abstract]   [Full Text] [Related]  

  • 16. Study of measles antibody in children.
    Rawat D; Chakravarti A; Yadav S
    Indian Pediatr; 2001 Nov; 38(11):1286-9. PubMed ID: 11721070
    [No Abstract]   [Full Text] [Related]  

  • 17. A survey of measles antibody in children.
    John TJ; Jesudoss ES
    Indian Pediatr; 1973 Feb; 10(2):65-6. PubMed ID: 4719649
    [No Abstract]   [Full Text] [Related]  

  • 18. Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination.
    Dilraj A; Sukhoo R; Cutts FT; Bennett JV
    Vaccine; 2007 May; 25(21):4170-4. PubMed ID: 17408818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measles susceptibility under one year of age and vaccination strategy.
    De Silva LM; Karlekar AV
    Med J Aust; 1994 Dec 5-19; 161(11-12):725. PubMed ID: 7830654
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimum age for measles immunization in Malaysia.
    Chen ST; Lam SK
    Med J Malaysia; 1985 Dec; 40(4):281-8. PubMed ID: 3842727
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.